Acrobiosystems Co

Acrobiosystems Co Retained Earnings

The Retained Earnings of Acrobiosystems Co (301080.SZ) as of Oct 18, 2026 is 402.09 M CNY. In the previous year, Retained Earnings was 334.20 M CNY — a change of 20.31% (higher).

Retained Earnings

402.09 MCNY

YoY

20.31%

Last updated:

Retained Earnings of Acrobiosystems Co is 2025 402.09 M CNY. Retained Earnings of Acrobiosystems Co was 2024 334.20 M CNY. It decreases by 20.31% higher compared to the previous year.

The Acrobiosystems Co Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
30.59 M CNY
Jan 1, 2019
35.87 M CNY
Jan 1, 2020
73.39 M CNY
Jan 1, 2021
225.76 M CNY
Jan 1, 2022
304.53 M CNY
Jan 1, 2023
318.43 M CNY
Jan 1, 2024
334.20 M CNY
Jan 1, 2025
402.09 M CNY
The Acrobiosystems Co Retained Earnings history
YEARRetained EarningsYoY
402.09 MCNY+20.31%
334.20 MCNY+4.95%
318.43 MCNY+4.57%
304.53 MCNY+34.89%
225.76 MCNY+207.63%
73.39 MCNY+104.57%
35.87 MCNY+17.26%
30.59 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Acrobiosystems Co Stock analysis

What does Acrobiosystems Co do? Acrobiosystems Co Ltd is a biotechnology company based in Beijing, China, operating within the Health Care sector. The company specializes in the development of biomedicine and bio-protein technology, focusing on recombinant proteins, detection services, and related products such as kits, antibodies, fillers, and culture media. With 597 full-time employees, Acrobiosystems provides services and products primarily for research and development (R&D) and production processes in the pharmaceutical and biotechnology industries. Its offerings support early drug discovery, verification, drug screening, optimization, diagnostic reagent development, and preclinical and clinical trials for various diseases, including tumors, autoimmune disorders, cardiovascular conditions, and infectious diseases. The company completed its initial public offering (IPO) on October 18, 2021, and is listed under the ticker symbol 301080.SZ with ISIN CNE100004S13. Acrobiosystems operates from its headquarters in Beijing, leveraging its technological expertise to contribute to advancements in drug development and diagnostic solutions. The company's website is https://www.acrobiosystems.cn/. Acrobiosystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acrobiosystems Co stock

Retained Earnings of Acrobiosystems Co is 402.09 M CNY in 2025.

Retained Earnings of Acrobiosystems Co changed from 334.20 M CNY to 402.09 M CNY, representing a 20.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Acrobiosystems Co since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Acrobiosystems Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Acrobiosystems Co

All Key Metrics — Acrobiosystems Co